Fludarabine/Cyclophosphamide Conditioning Regimen in Aplastic Anemia Patients Receiving Matched-Sibling Donor Transplant Is Non-inferior to ATG/Cyclophosphamide: A Single-Center Experience from Pakistan

Table 1

Baseline characteristics of acquired aplastic anemia patients ().

Median (interquartile range) (range)
Age (years)		16 (11-20) (3-48)
Time duration from diagnosis till transplant (months)		3 (2-4) (1–8)
Time duration from transplant till follow-up (months)		30 (8-55) (0-98)
		(%)
Age groups (years)	<18 years	77 (59.2)
	≥18 years	53 (40.8)
Gender	Male	89 (68.5)
	Female	41 (31.5)
Conditioning	Flu/Cy	88 (67.7)
	ATG/Cy	42 (32.3)
Cyclosporin	Yes	114 (87.7)
	No	16 (12.3)
Graft source	PB	81 (62.3)
	BM	34 (26.2)
	PB/BM	15 (11.5)